Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nancy Roach
Affiliation
Marti Nelson Cancer Foundation
ORCID
Career Start Year
2003
Papers
31
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
31343905
Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research Statement.
J Clin Oncol
2019
29803565
Factors affecting the communication experiences of newly diagnosed colorectal cancer patients.
Patient Educ Couns
2018
27658673
Engaging Patient Advocates and Other Stakeholders to Design Measures of Patient-Centered Communication in Cancer Care.
Patient
2017
30703315
A Randomized Controlled Study Comparing the National Cancer Institute's Original and Revised Consent Form Templates.
IRB
2017
28214167
Psychometric evaluation and design of patient-centered communication measures for cancer care settings.
Patient Educ Couns
2017
28345368
Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.
Clin Trials
2017
28968172
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.
J Clin Oncol
2017
28968170
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
J Clin Oncol
2017
29038296
A Blueprint to Advance Colorectal Cancer Immunotherapies.
Cancer Immunol Res
2017
26700120
Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.
J Clin Oncol
2016
26438111
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.
J Clin Oncol
2016
27742905
Addressing Patients' Priorities as a Strategy to Improve Value.
Oncologist
2016
27098014
Enhancing clinical evidence by proactively building quality into clinical trials.
Clin Trials
2016
26700123
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.
J Clin Oncol
2016
24467411
Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.
Eur J Cancer Care (Engl)
2015
26433549
Involving Advocates in Cancer Research.
Semin Oncol
2015
26182295
Losing "Losing the Battle With Cancer".
JAMA Oncol
2015
25993140
Perspectives on clinical trials for gastrointestinal malignancies.
Am Soc Clin Oncol Educ Book
2015
25452455
Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
J Clin Oncol
2015
24246567
Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model.
Med Decis Making
2014
24813474
Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study.
Patient Educ Couns
2014
24830357
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
2014
24686090
Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort study.
Clin Oncol (R Coll Radiol)
2014
23589552
Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.
J Clin Oncol
2013
24008432
Considerations for the successful co-development of targeted cancer therapies and companion diagnostics.
Nat Rev Drug Discov
2013
23015662
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.
Oncologist
2012
23169512
Advocates' perspective: neoadjuvant chemotherapy for breast cancer.
J Clin Oncol
2012
21737577
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice.
Oncologist
2011
20489186
Blinded independent central review of the progression-free survival endpoint.
Oncologist
2010
14754700
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
Obstet Gynecol
2004
12873173
Delivering human papillomavirus testing to the public: one patient advocate's perspective.
Arch Pathol Lab Med
2003
1 - 31 of 31
Column Actions
Search
Recommended Authors
Edward Christopher Dee
Memorial Sloan Kettering Cancer Center
Career Start Year
2017
Number of shared co-authors
0
Jessica A Lavery
Memorial Sloan Kettering Cancer Center
Career Start Year
2015
Number of shared co-authors
0
Donna R Rivera
Oncology Center of Excellence
Career Start Year
2012
Number of shared co-authors
2
Lawson Eng
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
2011
Number of shared co-authors
1
Jeremy L Warner
Vanderbilt University Medical Center
Career Start Year
2009
Number of shared co-authors
0
Erin E Hahn
Kaiser Permanente
Career Start Year
2008
Number of shared co-authors
0
Sunita Ghosh
Cross Cancer Institute
Career Start Year
2006
Number of shared co-authors
0
Peter Paul Yu
Hartford HealthCare Cancer Institute
Career Start Year
2006
Number of shared co-authors
1
Travis Osterman
Vanderbilt University Medical Center
Career Start Year
2004
Number of shared co-authors
0
Fay J Hlubocky
Maclean Center for Clinical Medical Ethics, University of Chicago Medicine
Career Start Year
2003
Number of shared co-authors
4
June M McKoy
Feinberg School of Medicine, Northwestern University
Career Start Year
2003
Number of shared co-authors
1
Nora Horick
Massachusetts General Hospital
Career Start Year
2003
Number of shared co-authors
2
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Career Start Year
2001
Number of shared co-authors
3
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year
2001
Number of shared co-authors
1
Deborah Collyar
Clinical Trials Information Project
Career Start Year
1999
Number of shared co-authors
3
Steven Joffe
Medical Ethics and Health Policy, University of Pennsylvania
Career Start Year
1999
Number of shared co-authors
2
Stacy W Gray
City of Hope Comprehensive Cancer Center
Career Start Year
1998
Number of shared co-authors
3
Thomas J George
UF Health Cancer Center
Career Start Year
1998
Number of shared co-authors
1
Craig C Earle
Odette Cancer Centre
Career Start Year
1996
Number of shared co-authors
1
Deborah Schrag
Memorial-Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
3
Nikolajs Zeps
Queensland University of Technology
Career Start Year
1996
Number of shared co-authors
0
Arash Naeim
University of California los angeles
Career Start Year
1994
Number of shared co-authors
0
Michael Brundage
Cancer Centre of Southeastern Ontario
Career Start Year
1993
Number of shared co-authors
0
Lois Shepherd
Queens University
Career Start Year
1991
Number of shared co-authors
0
Jeff A Sloan
Mayo Clinic
Career Start Year
1991
Number of shared co-authors
3
Mark Lawler
Queens University Belfast Belfast
Career Start Year
1988
Number of shared co-authors
1
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Career Start Year
1987
Number of shared co-authors
1
Charles L Bennett
University of South Carolina
Career Start Year
1986
Number of shared co-authors
4
Paul Harnett
Westmead Clinical School, University of Sydney
Career Start Year
1986
Number of shared co-authors
0
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year
1985
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Al B Benson
Northwestern University Feinberg School of Medicine
Co-authored papers
5
Emile E Voest
The Netherlands Cancer Institute
Co-authored papers
1
Nancy U Lin
Co-authored papers
1
Richard Simon
National Cancer Institute
Co-authored papers
1
Jeffrey Peppercorn
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
1
Jonathan M Marron
and Center for Bioethics, Harvard Medical School
Co-authored papers
1
Julia A Beaver
Center for Drug Evaluation and Research
Co-authored papers
1
Elena M Stoffel
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers
1
Mark J Ratain
University of Chicago
Co-authored papers
1
Martijn P Lolkema
Erasmus MC Cancer Institute
Co-authored papers
1
Alda L Tam
MD Anderson Cancer Center
Co-authored papers
1
Debra J H Mathews
Carlsberg Laboratory, Case Western Reserve University, Johns Hopkins Medicine, Johns Hopkins School of Medicine, Johns Hopkins School of Public Health, Johns Hopkins University, National Academy of Sciences, Pennsylvania State University, Presidential Commission for the Study of Bioethical Issues
Co-authored papers
1
Kathryn Levit
Co-authored papers
1
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers
1
Edwin Cuppen
Hartwig Medical Foundation
Co-authored papers
1
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers
1
Jeffrey C Allen
Co-authored papers
1
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Laura A Levit
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers
1
1 - 20